Your browser doesn't support javascript.
loading
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.
Erol, Cihan; Sendur Mehmet, Ali Nahit; Bilgetekin, Irem; Garbioglu, Duygu Bayir; Hamdard, Jamshid; Akbas, Sinem; Hizal, Mutlu; Arslan, Cagatay; Sevinc, Alper; Kucukarda, Ahmet; Erdem, Dilek; Kahraman, Seda; Cakir, Emre; Demirkiran, Aykut; On, Sercan; Dogan, Izzet; Erdogan, Atike Pinar; Koca, Sinan; Kubilay, Pinar; Eren, Orhan Onder; Cilbir, Ebru; Celik, Emir; Araz, Murat; Ozyukseler, Deniz Tataroglu; Yildirim, Mahmut Emre; Bahceci, Aykut; Taskaynatan, Halil; Oyman, Abdilkerim; Deniz, Gulhan Ipek; Menekse, Serkan; Kut, Engin; Gulmez, Ahmet; Sakin, Abdullah; Nayir, Erdinc; Acar, Ramazan; Sen, Erdem; Inal, Ali; Turhal, Serdar; Kaya, Ali Osman; Paydas, Semra; Tastekin, Didem; Hacibekiroglu, Ilhan; Cincin, Irfan; Bilici, Ahmet; Mandel, Nil Molinas; Dede, Didem Sener; Akinci, Muhammed Bulent; Oksuzoglu, Berna; Uncu, Dogan; Yalcin, Bulent.
Affiliation
  • Erol C; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Sendur Mehmet AN; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Bilgetekin I; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Garbioglu DB; Department of Medical Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Hamdard J; Department of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Akbas S; Department of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Hizal M; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Arslan C; Department of Medical Oncology, Izmir Medical Park Hospital, Izmir, Turkey.
  • Sevinc A; Department of Medical Oncology, Gaziantep Medical Park Hospital, Edirne, Turkey.
  • Kucukarda A; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  • Erdem D; Department of Medical Oncology, Samsun Medical Park Hospital, Samsun, Turkey.
  • Kahraman S; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
  • Cakir E; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
  • Demirkiran A; Department of Medical Oncology, Faculty of Medicine, Ege University, Izmir, Turkey.
  • On S; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Dogan I; Department of Medical Oncology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey.
  • Erdogan AP; Department of Medical Oncology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey.
  • Koca S; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Kubilay P; Department of Medical Oncology, Faculty of Medicine, Selcuk University, Konya, Turkey.
  • Eren OO; Department of Medical Oncology, Diskapi Training and Research Hospital, Ankara, Turkey.
  • Cilbir E; Department of Medical Oncology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey.
  • Celik E; Department of Medical Oncology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey.
  • Araz M; Department of Medical Oncology, Faculty of Medicine, Ege University, Izmir, Turkey.
  • Ozyukseler DT; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Yildirim ME; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Bahceci A; Department of Medical Oncology, Dr. Ersin Arslan Education and Research Hospital, Gaziantep, Turkey.
  • Taskaynatan H; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey.
  • Oyman A; Department of Medical Oncology, Umraniye Education and Research Hospital, Istanbul, Turkey.
  • Deniz GI; Department of Medical Oncology, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey.
  • Menekse S; Department of Medical Oncology Manisa City Hospital, Manisa, Turkey.
  • Kut E; Department of Medical Oncology Manisa City Hospital, Manisa, Turkey.
  • Gulmez A; Department of Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey.
  • Sakin A; Department of Medical Oncology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.
  • Nayir E; Department of Medical Oncology, Mersin Medical Park Hospital, Mersin, Turkey.
  • Acar R; Department of Medical Oncology, Gulhane Education and Research Hospital, Ankara, Turkey.
  • Sen E; Department of Medical Oncology, Mehmet Akif Ersoy Hospital, Canakkale, Turkey.
  • Inal A; Department of Medical Oncology, Mersin City Hospital, Mersin, Turkey.
  • Turhal S; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey.
  • Kaya AO; Department of Medical Oncology, Faculty of Medicine, Biruni University, Istanbul, Turkey.
  • Paydas S; Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Tastekin D; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey.
  • Hacibekiroglu I; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
  • Cincin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  • Bilici A; Department of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Mandel NM; Department of Medical Oncology, Istanbul American Hospital, Istanbul, Turkey.
  • Dede DS; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Akinci MB; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Oksuzoglu B; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, 5Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Uncu D; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Yalcin B; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
J Cancer Res Ther ; 18(12 Suppl 2): S347-S353, 2022 12.
Article in En | MEDLINE | ID: mdl-36510987
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Colorectal Neoplasms / Colonic Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: J Cancer Res Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2022 Type: Article Affiliation country: Turkey
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Colorectal Neoplasms / Colonic Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: J Cancer Res Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2022 Type: Article Affiliation country: Turkey